Stage 2 Study definition

Stage 2 Study means that portion of the Ongoing Biocon Study comprising a […***…].
View Source
Stage 2 Study means either a scoping study or a preliminary economic assessment, which, unless all parties agree otherwise, shall be in the form of a NI 43-101 compliant technical report, prepared by Eldorado in respect of a New Project (and if required, for ▇▇▇▇ purposes, to be prepared for ▇▇▇▇ by an independent qualified person (“QP”), then the Eldorado report will be incorporated into a stand-alone for ▇▇▇▇ by an independent QP, at ▇▇▇▇’▇ expense);
View Source
Stage 2 Study means [ * ].
View Source

Examples of Stage 2 Study in a sentence

  • Biocon shall, at its sole expense, conduct the Stage 2 Study, in accordance with Biocon’s protocol until the Stage 2 Study is completed or terminated, at its sole expense.

  • For clarity, Exelixis’ rights to Combined Therapy Regulatory Documentation related to the Exelixis Compound, including but not limited to Study Data arising from the Stage 1 Study and the Stage 2 Study (if applicable), are unchanged under the Agreement.

  • Exelixis hereby agrees that BMS has the right to exploit Stage 1 Combined Therapy Inventions and Combined Therapy Patent Rights (if any) solely as needed to (A) conduct a Stage 2 Study with a Third Party and (B) obtain Regulatory Approval of a combination therapy involving the BMS Compound and a Third Party Compound.

  • Section 9.7 of the Agreement is hereby amended to include the following after the last sentence: “Notwithstanding the above, the Parties agree that BMS has the unilateral right to publish or disclose Stage 1 Study Data and Stage 2 Study Data to the extent that such Study also evaluates a Third Party compound.

  • This is a reduction of 25.9% from the baseline; and 9.6% and 8.6% from the Scheme A and B proposed at the Stage 2 Study respectively in the operational phase.

  • The Tenant will be provided by the Landlord with a card or key giving access to the parking facility at all times.

  • Exelixis hereby acknowledges that it has received no assurances that the Exelixis Compound will be selected by BMS to conduct a Stage 2 Study and fully understands that BMS may select a Compound of a Third Party to conduct a Stage 2 Study.

  • Any presentation, publication or other disclosure (each a “Disclosure”), whether electronic, written or oral to any person or party not subject to an obligation of confidentiality pursuant to the Agreement, concerning or relating to the Stage 1 Study or the Stage 2 Study (solely to the extent that the Stage 2 Study includes the Exelixis Compound)shall first be provided by BMS to Exelixis for review and comment at least [ * ] prior to submission for publication or other disclosure.

  • BMS desires to conduct separate Stage 1 Studies with Exelixis and two Third Parties and, dependent on the results of such Stage 1 Studies, potentially conduct a Stage 2 Study with Exelixis.

  • Exelixis hereby agrees that BMS has the right to exploit Combined Therapy Regulatory Documentation related to combinations with Third Parties only, without accounting to Exelixis, solely for the limited purpose of (A) conducting a Stage 2 Study with a Third Party and (B) obtaining Regulatory Approval of a combination therapy involving the BMS Compound and a Third Party Compound.